Chlorprothixene

This classification denotes an antipsychotic agent with the molecular formula C18H18ClNS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9S7OD60EWP, chemically known as 3-(2-chlorothioxanthen-9-ylidene)-n,n-dimethyl-propan-1-amine but generally known as chlorprothixene, which bears US NIH Compound Identifier 2729. European Medicines Agency schedules Chlorprothixene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06210MIG. The term CHLORPROTHIXENE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 No. 2 1999, List 40). World Health Organization schedules chlorprothixene in its Anatomical Therapeutic Chemical (ATC) Classification. CHLORPROTHIXENE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule chlorprothixene under HS 29349910 and SITC 51579. As of Q4 2014, CHLORPROTHIXENE remains the US FDA Preferred Term for this commodity. Chlorprothixene bears US NLM identifiers UMLS ID C0008290 and NCI Concept Code C65325. SMILES: CLC1CC2/C(=C/CCN(C)C)C3C(SC2CC1)CCCC3.